LINBID 400 Tablet

About LINBID 400 Tablet

LINBID 400 400 mg is a tablet product of Biopharma Ltd. that contains Linezolid. Only the doctor can confirm whether it suits a person's infection.

There are 39 brands of Linezolid listed in Bangladesh. The lowest listed price is Linez 400 mg Tablet at ৳ 60.00 per unit.

What is LINBID 400 Tablet?

The tablet LINBID 400 contains Linezolid and is made by Biopharma Ltd. It acts by blocking a step in the way bacteria make proteins, which stops the bacteria from multiplying. It belongs to a group of antibiotics called oxazolidinones, which act in a different way from many other antibiotics: they stop bacteria from making the proteins they need to grow and multiply. The dose and duration are decided by the doctor based on the patient's condition.

Uses of LINBID 400

Only the doctor can confirm whether it suits a person's infection. It is not for viral infections such as colds or flu. The doctor will decide if LINBID 400 is appropriate for the infection.

How to use LINBID 400

Do not skip doses or stop early, even if you feel better, because stopping too soon can allow the infection to return. Swallow the tablet with water. LINBID 400 is taken by mouth. Take LINBID 400 400 mg tablet by mouth as directed by your doctor. If you miss a dose, ask your doctor or pharmacist what to do. The dose and length of treatment are decided by your doctor based on your condition.

Side effects of LINBID 400

Many of these are mild to moderate. Contact the doctor if you have repeated nausea or vomiting, or if you feel unwell in a way that worries you. Like all medicines, LINBID 400 400 mg tablet can cause side effects. Tell your doctor if any side effect bothers you or does not go away. Tell your doctor if you develop repeated nausea or vomiting, unexplained weakness, or any unusual symptoms while taking it.

Safety and precautions

It is pregnancy category C; use only if clearly needed. Pregnancy category C: use only if the benefit justifies the risk. It is not known if linLINBID 400 passes into breast milk, so breastfeeding mothers should ask their doctor first. Tell your doctor about all the other medicines you take.

Frequently asked questions

What does LINBID 400 treat?

Only the doctor can confirm whether it suits a person's infection. It is not for viral infections such as colds or flu.

How should I take LINBID 400?

Do not skip doses or stop early, even if you feel better, because stopping too soon can allow the infection to return. Swallow the tablet with water.

What are the side effects of LINBID 400?

Many of these are mild to moderate. Contact the doctor if you have repeated nausea or vomiting, or if you feel unwell in a way that worries you.

Is LINBID 400 safe for everyone?

It is pregnancy category C; use only if clearly needed. Pregnancy category C: use only if the benefit justifies the risk.

Indications

Vancomycin-Resistant Enterococcus faecium infections including cases with concurrent bacteremia.

Nosocomial pneumonia caused by Staphylococcus aureus (methicillin-susceptible and -resistant strains) or Streptococcus pneumoniae (including multi-drug resistant strains). Combination therapy ... Read moreVancomycin-Resistant Enterococcus faecium infections including cases with concurrent bacteremia.

Nosocomial pneumonia caused by Staphylococcus aureus (methicillin-susceptible and -resistant strains) or Streptococcus pneumoniae (including multi-drug resistant strains). Combination therapy may be clinically indicated if the documented or presumptive pathogens include Gram-negative organism.

Complicated skin and skin structure infections, including diabetic foot infections (without concomitant osteomyelitis) caused by Staphylococcus aureus (methicillin-susceptible and methicillin-resistant strains), Streptococcus pyogenes or Streptococcus agalactiae.

Uncomplicated skin and skin structure infections caused by Staphylococcus aureus (methicillin-susceptible only) or Streptococcus pyogenes.

Community-acquired pneumonia caused by Streptococcus pneumoniae (including multi-drug resistant strains) including cases with concurrent bacteremia or Staphylococcus aureus (methicillin-susceptible strains only).

Pharmacology

Linezolid is a synthetic, antibacterial agent belonging to a new class of antibiotics, the oxazolidinones, with in vitro activity against Gram positive aerobic bacteria, some Gram positive anaerobic bacteria and certain Gram negative bacteria. It selectively inhibits bacterial protein synthesis via a mechanism of action different from that of other antibacterial agents. Linezolid binds to the 23S ribosomal RNA of the 50S subunit of the bacterial ribosome and prevents the formation of a functional 70S initiation complex which is an essential component of the bacterial translation process. The results of time-kill studies have shown Linezolid to be bacteriostatic against enterococci and staphylococci. For streptococci, Linezolid was found to be bactericidal for the majority of strains.

Dosage & Administration

Patients who commence treatment on the parenteral formulation may be switched to oral presentation when clinically indicated. In such circumstances, no dose adjustment is required as Linezolid has an oral bioavailability of approximately 100%. The injection should be administered over a period of 30 to 120 minutes. The film-coated tablets or oral suspension may be taken with or without food.

Complicated skin and skin structure infections, Community-acquired pneumonia, including concurrent bacteremia-
  • Pediatric Patients (Birth through 11 Years of Age): 10 mg/kg IV or oral t.i.d.
  • Adults and Adolescents (12 Years and Older): 600 mg IV or oral b.i.d.
  • Recommended Duration of Treatment (consecutive days): 10 to 14
Nosocomial pneumonia, Vancomycin-resistant Enterococcus faecium infections including concurrent bacteremia-
  • Pediatric Patients (Birth through 11 Years of Age): 10 mg/kg IV or oral t.i.d.
  • Adults and Adolescents (12 Years and Older): 600 mg IV or oral b.i.d.
  • Recommended Duration of Treatment (consecutive days): 14 to 28
Uncomplicated skin and skin structure infections-
  • Pediatric Patients (Birth through 11 Years of Age): <5 yrs: 10 mg/kg oral t.i.d. 5-11 yrs: 10 mg/kg oral b.i.d
  • Adults and Adolescents (12 Years and Older): Adults: 400 mg oral b.i.d. Adolescents: 600 mg oral b.i.d
  • Recommended Duration of Treatment (consecutive days): 10 to 14
Neonates <7 days: Most pre-term neonates <7 days of age (gestational age <34 weeks) have lower systemic Linezolid clearance values and larger AUC values than many full-term neonates and older infants. These neonates should be initiated with a dosing regimen of 10 mg/kg every 12 hours. Consideration may be given to the use of 10 mg/kg in every eight hours regimen in neonates with a sub-optimal clinical response. All neonatal patients should receive 10 mg/kg t.i.d. by 7 days of life.

Interaction

Monoamine Oxidase Inhibition: Linezolid is a reversible and nonselective inhibitor of monoamine oxidase. Therefore, Linezolid has the potential for interaction with adrenergic and serotonergic agents.

Adrenergic Agents: Some individuals receiving Linezolid may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic agents, vasopressor or dopaminergic agents. Initial doses of adrenergic agents such as dopamine or epinephrine should be reduced and titrated to achieve the desired response.

Serotonergic Agents: Physicians should be alert to the possible signs and symptoms of serotonergic syndrome in patients receiving concomitant Linezolid and serotonergic agents.

Contraindications

Linezolid formulations are contraindicated for using in patients who have known hypersensitivity to Linezolid or any of the other product components. Linezolid should not be used in patients taking any medicinal product which inhibits monoamine oxidases A or B (e.g. Phenelzine, Isocarboxazid) or within two weeks of taking any such medicinal product. Linezolid should not be administered to patients with uncontrolled hypertension, pheochromocytoma, thyrotoxicosis, carcinoid syndrome and/or patients taking directly and indirectly acting sympathomimetic agents (e.g. Pseudoephedrine), vasopressive agents (e.g. Epinephrine, Norepinephrine), dopaminergic agents (e.g. Dopamine, Dobutamine), serotonin re-uptake inhibitors, tricyclic antidepressants, serotonin 5-HT1 receptor agonists (triptans), meperidine or buspirone.

Side Effects

Most of the adverse events reported with Linezolid were mild to moderate in intensity. The most common adverse events in patients treated with Linezolid were diarrhea, headache and nausea. Other adverse events includes oral moniliasis, vaginal moniliasis, hypertension, dyspepsia, localized abdominal pain, pruritus, and tongue discoloration.

Pregnancy & Lactation

Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Linezolid should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether Linezolid is excreted in human milk. Because many drugs are excreted in human milk. Caution should be exercised when Linezolid is administered to a nursing woman.

Precautions & Warnings

Patients who develop recurrent nausea or vomiting, unexplained acidosis or low bicarbonate level while receiving Linezolid should receive immediate medical evaluation. Where administration of Linezolid and concomitant serotonergic agents are clinically appropriate, patients should be closely observed for signs and symptoms of serotonin syndrome such as cognitive dysfunction, hyperpyrexia, hyperreflexia and incoordination. If signs or symptoms occur, physicians should consider discontinuation of either one or both agents. If the concomitant serotonergic agent is withdrawn, discontinuation symptoms can be observed. If patients experience symptoms of visual impairment, such as changes in visual acuity, changes in color vision, blurred vision or visual field defect, prompt ophthalmic evaluation is recommended. Convulsions have been reported in patients when treated with Linezolid. In some of these cases, a history of seizures or risk factors for seizures was reported.

Overdose Effects

No cases of overdose have been reported. Symptomatic and supportive care is advised together with maintenance of glomerular filtration. Approximately 30% of a Linezolid dose is removed during 3 hours of haemodialysis. No data are available for the removal of Linezolid by peritoneal dialysis or haemoperfusion.

Storage Conditions

Linezolid formulations should be stored at room temperature (15°C-30°C), away from light and moisture. All medicines should be kept away from children.

Alternative brands of Linezolid

Other brands with the same generic name, cheapest first.

Anulid Tablet

400 mg

Linezolid

Healthcare Pharmaceuticals Ltd.

৳ 60.00 per unit

Arlin Tablet

400 mg

Linezolid

Beximco Pharmaceuticals Ltd.

৳ 60.00 per unit

Ezolid Tablet

400 mg

Linezolid

Advanced Chemical Industries PLC

৳ 60.00 per unit

Anulid Tablet

600 mg

Linezolid

Healthcare Pharmaceuticals Ltd.

৳ 85.00 per unit

Arlin Tablet

600 mg

Linezolid

Beximco Pharmaceuticals Ltd.

৳ 85.00 per unit

Ezolid Tablet

600 mg

Linezolid

Advanced Chemical Industries PLC

৳ 85.00 per unit

Lizen Tablet

600 mg

Linezolid

Zenith Pharmaceuticals Ltd.

৳ 85.00 per unit

See all 39 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.